Evidence map›Paper›PMID 42909061›Full record

ReviewiScience2026

Chemical modifications to enhance the stability of DNA nanoparticles for biological applications.

Alexis R Glumm, Divita Mathur

Abstract readReview
In one paragraph

Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexis R GlummDepartment of Chemistry, Case Western Reserve University, Cleveland OH 44106, USA.
Divita MathurDepartment of Chemistry, Case Western Reserve University, Cleveland OH 44106, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic DNA nanoparticles offer unique modularity and chemical versatility to build systems for biomedical applications. Extensive research into DNA nanoparticles has led to superior control over loading therapeutic cargo, adding targeting and imaging moieties, and designing desired geometries. One of the main barriers to translating DNA nanoparticles into clinical therapies, however, is their stability in biological environments. Introduction of DNA nanoparticles in biological environments exposes them to various stressors such as nuclease enzymes, depleted salt conditions, and alterations in oxidizing conditions. It is therefore necessary to develop strategies to protect DNA nanoparticles against such stressors to preserve their structural integrity and function. In this review, we highlight dominant chemical modifications that have been optimized to secure DNA nanoparticles against stressors with a focus on biological applications. We provide comprehensive accounts of notable examples from recent results and discuss aspects of DNA nanoparticle stability that require the community's attention.

Indexed as

biomineralizationDNA nanoparticlesDNA origamiDNasefetal bovine serumlipid encapsulationnoncanonical nucleic acidsnucleasespeptoidspolylysineUV crosslinking

Identifiers

PMID42909061
PMCPMC13683714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.